Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

AMG-386/sorafenib combination shows promise in metastatic renal cell carcinoma

Feb. 28, 2011

Everolimus is active in patients with transitional cell carcinoma of the urothelium

Feb. 28, 2011

Phase II pazopanib trial in urothelial cancer closed due to lack of activity

Feb. 28, 2011

NCI develops anticancer monoclonal antibodies targeting mesothelin

Feb. 28, 2011

Additional phase II data reported on paclitaxel nanoparticles in urothelial cancer

Feb. 28, 2011

CD151 antigen is a marker of prostate cancer recurrence after radical prostatectomy

Feb. 25, 2011

Epidermal growth factor receptor may be marker of progression of penile squamous cancer

Feb. 25, 2011

BMS-936558 shows promise in RCC and mCRPC in phase I trial

Feb. 25, 2011

AR-42 displays potent antitumor effects in models of embryonal carcinoma

Feb. 25, 2011

Intraprostatic administration of PROSTVAC VF cancer vaccine is feasible and safe

Feb. 24, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...